We are submitting to the exchange newspaper advertisements of abridged unaudited standalone and consolidated financial results for the quarter ended 31.12.2024.

pdf

Bal Pharma Ltd.

14 Feb 2025

89.30

6.32%

Corp. Note

BAL PHARMA LTD. - 524824 - Integrated Filing (Financial)

BSE India

We are submitting to the exchange , integrated filing ( Finance) for the quarter ended 31.12.2024.

pdf

Bal Pharma Ltd.

13 Feb 2025

89.30

6.32%

Result

BAL PHARMA LTD. - 524824 - Standalone And Consolidated Financial Results For The Quarter Ended 31.12.2024.

BSE India

The Board of Directors at their meeting held on 13.02.2025 has taken on record and approved Un audited financial results of the Company for the quarter ended 31.12.2024. Copy of the financial results together with limited review report issued by statutory auditors is enclosed.

pdf

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	73.66	73.49	81.76	0.2%	-9.9%
Operating Profit Qtr	7.76	7.70	7.79	0.8%	-0.4%
Net Profit Qtr	0.48	1.04	0.89	-53.8%	-46.1%
Earning Per Share Adjusted latest Qtr	0.30	0.65	0.56	-53.8%	-46.4%

* Consolidated data

Detailed Results

Bal Pharma Ltd.

13 Feb 2025

89.30

6.32%

Result

BAL PHARMA LTD. - 524824 - Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended …

BSE India

The Board of Directors at their meeting held on 13.02.2025 has inter alia taken on record and approved the stand alone and consolidated financial results of the Company. Copy of financial results , Limited review report issued by statutory auditors together with declaration of unmodified opinion is enclosed . Please take the same on record.

pdf

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	73.66	73.49	81.76	0.2%	-9.9%
Operating Profit Qtr	7.76	7.70	7.79	0.8%	-0.4%
Net Profit Qtr	0.48	1.04	0.89	-53.8%	-46.1%
Earning Per Share Adjusted latest Qtr	0.30	0.65	0.56	-53.8%	-46.4%

* Consolidated data

Detailed Results

Bal Pharma Ltd.

13 Feb 2025

89.30

6.32%

Board Meeting

BAL PHARMA LTD. - 524824 - Board Meeting Outcome for Outcome Of The Board Meeting

BSE India

Board of Directors at their meeting held on 13.02.2024 has inter alia , 1.Taken on record and approved Unaudited stand alone and consolidated financial results for the quarter and 9 months ended 31.12.2024. 2. Differed to consider fund raising options due to unfavorable and volatile market conditions.

pdf

Bal Pharma Ltd.

24 Jan 2025

89.30

6.32%

Board Meeting

BAL PHARMA LTD. - 524824 - Board Meeting Intimation for Board Meeting Intimation

BSE India

BAL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve Unaudited standalone and consolidated financial results for the quarter ended 31.12.2024 and to consider fund raising options .

pdf